SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-049746
Filing Date
2017-08-07
Accepted
2017-08-07 09:12:54
Documents
68
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-18651_110q.htm 10-Q 1157557
2 EX-10.4 a17-18651_1ex10d4.htm EX-10.4 68392
3 EX-10.5 a17-18651_1ex10d5.htm EX-10.5 68761
4 EX-31.1 a17-18651_1ex31d1.htm EX-31.1 13061
5 EX-31.2 a17-18651_1ex31d2.htm EX-31.2 13036
6 EX-32.1 a17-18651_1ex32d1.htm EX-32.1 6214
7 EX-32.2 a17-18651_1ex32d2.htm EX-32.2 6888
  Complete submission text file 0001104659-17-049746.txt   5121262

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nbrv-20170630.xml EX-101.INS 1025056
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbrv-20170630.xsd EX-101.SCH 45957
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbrv-20170630_cal.xml EX-101.CAL 54065
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbrv-20170630_def.xml EX-101.DEF 138071
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT nbrv-20170630_lab.xml EX-101.LAB 385668
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbrv-20170630_pre.xml EX-101.PRE 291200
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37558 | Film No.: 171010250
SIC: 2834 Pharmaceutical Preparations